CureVac has a total of 1901 patents globally, out of which 931 have been granted. Of these 1901 patents, more than 51% patents are active. The United States of America is where CureVac has filed the maximum number of patents, followed by Europe (EPO) and Germany. Parallelly, United States of America seems to be the main focused R&D center of CureVac and Germany is the origin country of CureVac.
CureVac was founded in the year 2000. CureVac is a biotechnology company specializing in mRNA-based therapeutics and vaccines for infectious diseases, cancer, and rare diseases.
Do read about some of the most popular patents of CureVac which have been covered by us in this article and also you can find CureVac patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over CureVac patent portfolio.
How many patents does CureVac have?
CureVac has a total of 1901 patents globally. These patents belong to 184 unique patent families. Out of 1901 patents, 985 patents are active.
How Many Patents did CureVac File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
| Year of Patents Filing or Grant | CureVac Applications Filed | CureVac Patents Granted |
| 2025 | 1 | 16 |
| 2024 | 33 | 43 |
| 2023 | 56 | 88 |
| 2022 | 100 | 89 |
| 2021 | 91 | 103 |
| 2020 | 73 | 130 |
| 2019 | 124 | 102 |
| 2018 | 116 | 87 |
| 2017 | 135 | 58 |
| 2016 | 269 | 40 |
| 2015 | 106 | 40 |
| 2014 | 179 | 47 |
How many CureVac patents are Alive/Dead?
Worldwide Patents
How Many Patents did CureVac File in Different Countries?
Countries in which CureVac Filed Patents
| Country | Patents |
| United States Of America | 377 |
| Europe (EPO) | 245 |
| Germany | 115 |
| Singapore | 88 |
| Austria | 85 |
| Japan | 82 |
| Canada | 79 |
| India | 71 |
| China | 68 |
| Australia | 64 |
| Spain | 60 |
| Brazil | 46 |
| Korea (South) | 45 |
| Mexico | 43 |
| Russia | 41 |
| Denmark | 35 |
| Israel | 26 |
| Poland | 16 |
| Italy | 16 |
| Hong Kong (S.A.R.) | 15 |
| Portugal | 14 |
| United Kingdom | 12 |
| Norway | 10 |
| South Africa | 5 |
| Slovenia | 5 |
| Croatia | 5 |
| Estonia | 5 |
| Slovakia | 5 |
| Hungary | 4 |
| Cyprus | 3 |
| Africa | 3 |
| Serbia | 2 |
| Eurasia | 2 |
| Malta | 2 |
| Albania | 2 |
| Lithuania | 2 |
| Turkey | 1 |
| Viet Nam | 1 |
| New Zealand | 1 |
| Malaysia | 1 |
| Taiwan | 1 |
| Philippines | 1 |
| Ukraine | 1 |
| Peru | 1 |
| Argentina | 1 |
| Montenegro | 1 |
| Indonesia | 1 |
| France | 1 |
| Chile | 1 |
Where are Research Centers of CureVac Patents Located?
10 Best CureVac Patents
WO2009127230A1 is the most popular patent in the CureVac portfolio. It has received 588 citations so far from companies like Moderna Therapeutics, GlaxoSmithKline and Modernatx Inc.
Below is the list of 10 most cited patents of CureVac:
| Publication Number | Citation Count |
| WO2009127230A1 | 588 |
| WO2012013326A1 | 504 |
| WO2012019780A1 | 467 |
| WO2010037539A1 | 459 |
| WO2008083949A2 | 430 |
| WO2009030481A1 | 401 |
| US20120258046A1 | 371 |
| US20050250723A1 | 345 |
| US20080025944A1 | 337 |
| WO2012019630A1 | 316 |
What are CureVac key innovation segments?
What Technologies are Covered by CureVac?
The chart below distributes patents filed by CureVac in different countries on the basis of the technology protected in patents. It also represents the markets where CureVac thinks it’s important to protect particular technology inventions.
R&D Focus: How has CureVac search focus changed over the years?
EXCLUSIVE INSIGHTS COMING SOON!
Interested in knowing about the areas of innovation that are being protected by CureVac?
